Trial Profile
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRA-Ramadan
- Sponsors Novo Nordisk
- 06 Jun 2015 Results from this study presented on 06 June 2015 at the 75th Annual Scientific Sessions of the American Diabetes Association in Boston, MA, USA.
- 06 Jun 2015 Results from this study published in a Novo Nordisk Media Release.
- 05 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.